Notably, inhibiting the leukotriene-producing enzyme arachidonate 5-lipoxygenase (Alox5) through genetic or pharmacological interventions can abolish the pro-metastatic activity of neutrophils, thereby reducing the transfer of breast cancer cells to the lungs (Wculek and Malanchi, 2015). Here, ALOX5 is linked to breast cancer.